Bokf Na lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 7.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 137,208 shares of the company’s stock after selling 10,711 shares during the period. Bokf Na owned 0.06% of Cardinal Health worth $21,536,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. Kepler Cheuvreux Suisse SA purchased a new position in shares of Cardinal Health during the 3rd quarter valued at about $36,133,000. Mackenzie Financial Corp increased its holdings in Cardinal Health by 19.4% in the 3rd quarter. Mackenzie Financial Corp now owns 34,649 shares of the company’s stock worth $5,439,000 after acquiring an additional 5,626 shares in the last quarter. Franklin Resources Inc. increased its holdings in Cardinal Health by 55.3% in the 3rd quarter. Franklin Resources Inc. now owns 487,089 shares of the company’s stock worth $76,453,000 after acquiring an additional 173,462 shares in the last quarter. Van ECK Associates Corp raised its stake in Cardinal Health by 1.4% during the 3rd quarter. Van ECK Associates Corp now owns 33,759 shares of the company’s stock worth $5,299,000 after acquiring an additional 458 shares during the period. Finally, Banque Cantonale Vaudoise lifted its holdings in Cardinal Health by 1.7% during the third quarter. Banque Cantonale Vaudoise now owns 20,276 shares of the company’s stock valued at $3,183,000 after purchasing an additional 343 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have weighed in on CAH shares. Argus upped their price target on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Mizuho raised their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research report on Friday, February 6th. Jefferies Financial Group upped their target price on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 22nd. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the stock from $190.00 to $244.00 in a research note on Friday, January 9th. Finally, Wells Fargo & Company raised their price target on Cardinal Health from $237.00 to $256.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $245.67.
Cardinal Health Stock Performance
CAH stock opened at $215.23 on Thursday. The company’s fifty day moving average price is $216.33 and its 200-day moving average price is $191.20. Cardinal Health, Inc. has a one year low of $120.72 and a one year high of $233.60. The company has a market capitalization of $50.65 billion, a PE ratio of 30.97, a price-to-earnings-growth ratio of 1.40 and a beta of 0.65.
Cardinal Health (NYSE:CAH – Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The firm had revenue of $65.63 billion during the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. Cardinal Health’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.93 earnings per share. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a dividend of $0.5107 per share. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is presently 29.35%.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Recommended Stories
- Five stocks we like better than Cardinal Health
- The gold chart Wall Street is terrified of…
- “This AI Giant is About to Go Bust”
- I tried out Elon Musk’s new AI tech — it floored me
- Elon Musk’s $1 Quadrillion AI IPO
- Is Trump Done? Shocking leak…
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
